| Univariate analysis | Multivariable analysis | ||
---|---|---|---|---|
 | β (95% CI) | P-value | β (95% CI) | P-value |
Age, years | 0.056 (0.051 to 0.060) | < 0.001 | 0.054 (0.050 to 0.059) | < 0.001 |
Sex, male | 0.025 (− 0.057 to 0.107) | 0.555 | − 0.012 (− 0.089 to 0.065) | 0.756 |
Body mass index, kg/m2 | − 0.001 (− 0.014 to 0.013) | 0.935 | − 0.008 (− 0.021 to 0.005) | 0.217 |
Use of antihypertensives | 0.384 (0.278 to 0.489) | < 0.001 | 0.168 (0.069 to 0.267) | 0.001 |
Use of antiplatelet agents | 0.305 (0.155 to 0.455) | < 0.001 | − 0.019 (− 0.158 to 0.120) | 0.785 |
Systolic blood pressure, mmHg | 0.010 (0.008 to 0.013) | < 0.001 | – | – |
Diastolic blood pressure, mmHg | 0.008 (0.005 to 0.012) | < 0.001 | – | – |
Hemoglobin A1c, %* | 1.022 (0.614 to 1.431) | < 0.001 | – | – |
Fasting glucose, mg/dL* | 0.648 (0.409 to 0.886) | < 0.001 | – | – |
Insulin, µU/mL* | 0.086 (0.017 to 0.154) | 0.014 | – | – |
HOMA-IR* | 0.104 (0.041 to 0.166) | 0.001 | – | – |
Total cholesterol, mg/dL | − 0.001 (− 0.002 to 0.000) | 0.206 | – | – |
LDL cholesterol, mg/dL | − 0.002 (− 0.003 to 0.000) | 0.026 | – | – |
HDL cholesterol, mg/dL | 0.000 (− 0.003 to 0.003) | 0.980 | – | – |
Triglyceride, mg/dL* | 0.088 (0.005 to 0.171) | 0.037 | – | – |
White blood cell counts, × 103/μL | 0.051 (0.026 to 0.075) | < 0.001 | 0.040 (0.017 to 0.064) | 0.001 |
hs-CRP, mg/dL* | 0.012 (− 0.015 to 0.040) | 0.378 | – | – |
TyG index | 0.126 (0.054 to 0.198) | 0.001 | 0.084 (0.013 to 0.154) | 0.020 |